NPJP.F Nephros, Inc.

Healthcare Medical Instruments & Supplies Frankfurt Exchange
2.70 EUR
Close of Nov 12, 2026
2.32 4.88
Market cap
EUR 29.3M
P/E
19.3x
P/B
2.55x
ROE
19.6%
Dividend yield
-
Fundamental score
-

Ratios use the latest price and the current fiscal year annualized from 3 quarters up to Sep 2026.

Is NPJP.F undervalued?

Graham number
Price2.70
Graham value1.83
Premium47.8%

NPJP.F trades 47.8% above its Graham number.

Graham number = √(22.5 × EPS × book value per share): the most a defensive investor should pay according to Benjamin Graham. An estimate, not a recommendation to buy or sell. How is it calculated?

Nephros, Inc. fundamental analysis

No fundamental analysis for Nephros, Inc. yet.

Nephros, Inc. stock price

Prices on the chart can differ slightly from the closing prices StockSummer uses for its ratios.

About Nephros, Inc.

Nephros, Inc., a commercial-stage company, develops and sells water filtration solutions for medical and commercial applications in the United States. It offers ultrafiltration products that are used in dialysis centers for the removal of biological contaminants from water and bicarbonate concentrate; and in hospitals for the prevention of infection from waterborne pathogens, such as legionella and pseudomonas, as well as in foodservice and hospitality, and other healthcare …

Full company profile